New CFO with Novartis experience

Mukul Mehta succeeds Harry Kirsch as Novartis CFO in March. Kirsch had been CFO since 2013 and is leaving the Basel-based biotech and pharma company after 22 years. Mehta is considered to be very experienced in the field of finance. He has also been with Novartis for 20 years and has held various management positions in finance in France, Poland and Norway. This experience has given him a deep understanding of Novartis. He was recently appointed Head of BPA, Digital Finance and Tax, where he will remain until March 2027. He holds a degree in management from the Jamnalal Bajaj Institute of Management Studies in India and an MBA from INSEAD France.

Mehta said: “I’ve had the privilege of growing with this company and working alongside exceptional colleagues. I look forward to continuing our journey as a focused medicines company and delivering sustainable value for patients and shareholders.”